Although EMR1 can be an unfavorable prognostic biomarker in macrophage-rich CRC, more studies would be needed to identify the unknown ligand and signaling pathway of EMR1, which may provide further insights into how EMR1 is activated and related to LNM and RFS. Here, ADGRE1 is linked to colorectal carcinoma.